검색어: characteristics (독일어 - 그리스어)

budgetary characteristics :
budgetary characteristics

characteristics and objectives
characteristics and objectives

budgetary characteristics (add rows if necessary) :
budgetary characteristics (add rows if necessary):

annex 2 - list of relevant changeover characteristics
annex 2 – list of relevant changeover characteristics

characteristics and objectives details of the context of the proposal are required in the explanatory memorandum .
characteristics and objectives details of the context of the proposal are required in the explanatory memorandum .

budget characteristics type of expenditure new efta contribution yes contributions form applicant countries yes heading in financial perspective no 3 internal policies
budget characteristics type of expenditure new efta contribution yes contributions form applicant countries yes heading in financial perspective no 3 internal policies

titel des dokuments antimicrobials for general use in target animal species summary of product characteristics for antimicrobial products efficacy requirements for ectoparasiticides for cattle fluid therapy
Τίτλος εγγράφου antimicrobials for general use in target animal species summary of product characteristics for antimicrobial products efficacy requirements for ectoparasiticides for cattle fluid therapy

the research will assess co 2 emissions and energy consumption on farms based on climatic characteristics, type of crops, and type of farming.
the research will assess co2 emissions and energy consumption on farms based on climatic characteristics, type of crops, and type of farming.

gemäß der guideline on summary of product characteristics (smpc) sollte dies auch im abschnitt 4.5 der smpc genannt werden.
Σύμφωνα με την Κατευθυντήρια Γραμμή για την Περίληψη των Χαρακτηριστικών του Προϊόντος (ΠΧΠ) αυτό θα πρέπει επίσης να αναφέρεται στην παράγραφο 4.5 της ΠΧΠ.

die häufigkeitskategorie "selten" wurde gemäß der guideline on summary of product characteristics (smpc) (rev.
Η κατηγορία συχνότητας ως «σπάνιες» ορίσθηκε σύμφωνα με την Οδηγία Α στην Περίληψη των Χαρακτηριστικών του Προϊόντος (ΠΧΠ) (αναθεώρηση 2, Σεπτ.

budgetary characteristics ( add rows if necessary ) : type of expenditure new efta contribution contributions from applicant countries heading in financial perspective no 3
budgetary characteristics ( add rows if necessary ) : type of expenditure new efta contribution contributions from applicant countries heading in financial perspective no 3

prospective planning of pharmacovigilance notice to applicants – guideline on the summary of product characteristics (ec december 1999 – revised version)
prospective planning of pharmacovigilance notice to applicants – guideline on the summary of product characteristics (ec december 1999 – revised version)

budgetary characteristics ( add rows if necessary ) : n / a budget line type of expenditure new efta contribution contributions from applicant countries heading in financial perspective
budgetary characteristics ( add rows if necessary ) : n / a budget line type of expenditure new efta contribution contributions from applicant countries heading in financial perspective

bitte beachten sie die zusammenfassung der merkmale des arzneimittels (summary of product characteristics - smpc) von paclitaxel, docetaxel oder eines aromatasehemmers zur dosisreduktion oder zu intervallverlängerungen.
Για πληροφορίες σχετικά με τη μείωση ή την καθυστέρηση της δόσης, ανατρέξατε στην Περίληψη των Χαρακτηριστικών του Προϊόντος (Π.Χ.Π.) για την πακλιταξέλη, τη δοσεταξέλη ή για τον αναστολέα αρωματάσης.

core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti-d immunoglobulin for intravenous and/or intramuscular use (cpmp/bpwg/574/99)
core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti- d immunoglobulin for intravenous and/ or intramuscular use (cpmp/ bpwg/ 574/ 99)